Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001(TGF-beta Trap)

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要